Smaller sterile filters improve yield
Reduced-size Supor™ Prime filters maximize product recovery
Monoclonal antibodies (mAbs), antibody-drug conjugates, and recombinant proteins are growing in importance as therapeutics. Developing highly concentrated mAbs brings new challenges to the production process. Understanding how to streamline your processes without compromising on quality is crucial to your success.
The growth in high-concentration formulations for subcutaneous injections brings new challenges to biopharmaceutical manufacturing, affecting processing time and product recovery. Learn how you can elevate your platform for viscous drug formulations with our solutions for concentration, filtration, formulation, and filling.
High-concentration formulations largely impact manufacturing, from ultrafiltration to sterile filtration, filling, mixing, and storage. Good solutions should maintain quality, maximize product recovery, and are adaptable to existing manufacturing platforms. Discover how Cytiva technologies can help maximize your process.